view all sponsors
  • IAR Cluster
  • SNC Lavalin
  • DSM


Programme Overview for 2014

Commercialisation and funding of the biobased economy - EFIB 2014

With EFIB's trademark theme of business meets policy, EFIB is consistent in attracting an unrivalled calibre of speakers from across policy and business and this will be no different for 2014. The full agenda has now been announced and below we have also shared with you the highlights from our indepth topic focus sessions, delving into commercialisation and scale-up of the biobased economy, and how national policies have aided industrial development, funding the biobased economy and competitive, resource efficient feedstocks. Plus, the ever-popular innovation track will truly showcase products and processes that have been successful in reaching commercialisation, in addition to those that are on the current scale-up pathway.

View the full agenda now - DAY ONE and DAY TWO!

Programme Highlights

In the opening plenary

Thierry Capelle, General Manager, New Business Development Group, Shell Chemicals
Francois de Bie, Chair, European Bioplastics Association
Daniele Ferrari, CEO, Versalis SpA

Join the discussion: feedstocks for the Future; what does the shale gas boom mean for Europe's transition to a biobased economy?
In the closing plenary

Stephan Tanda, Chair IB Council and Managing Board Member, DSM
Dr Klaus Stadler, European Director of Environmental and Water Resources, The Coca-Cola Company
Neil Parry, Biotechnology Leader, Unilever

Join the discussion: Building a sustainable biobased economy: meeting the challenges of an emerging value chain
In the global scale up - policy in practise session:

Policy turned into practice to advance the biobased economy in Canada
David Harris Kolada, Vice President, Alliances & Market Development, Sustainable Development Technology Canada
In the innovation track:

Innovative enzyme formulations unlocking the path to low cost lignocellulosic sugars
Alex Michine, CEO, MetGen

In the innovation track:

The fragrant wind of change: Cyanobacteria fragrance and flavour production in Dutch greenhouses
Michiel Lensink, CEO, Photanol BV
In the financing round table:

- Daan Dijk, Managing Director, Rabobank
- Ron Weerdmeester, PNO
- Denis Lucquin, Managing Director, Sofinova Partners
In the sustainable and competitive feedstocks track:

Overview of the current state of the feedstocks market
David Turley, Company Executive and Lead Consultant Biobased Feedstocks, NNFCC
In the global scale up - policy in practise session:

Commercial scale up case study and potential of bioplastics in Thailand
Dr Pipat Weerathaworn, President, Thai Bioplastic Industry Association (TBIA)
In the innovation track:

Commercialising Renewable Butanol
Sean Sutcliffe, Chief Executive, Green Biologics Ltd

In the opening plenary:

Industry Perspectives; successfully using renewable resources and scale-up of plant production facilities in France
Jean Luc Dubois, Scientific Director, Arkema
Alain Commissaire, CEO, Cristal Union

In the BIO-TIC chemical building blocks session:

Elsbeth Roelofs, Senior Business Consultant, TNO and Claire Gray, Project Coordinator, Industrial Biotechnology, EuropaBio will focus on actions for IB innovation for chemical building blocks
In the sustainable and competitive feedstocks track:

Farmer viewpoint - future feedstock availability and European competitiveness compare with other regions in the world
Pascal Prot, President, Vivescia

View the pre-conference workshops here >>

You can also visit the EFIB speaker page to view the profiles of these speakers and more.

EFIB is organised by EuropaBio and Smithers Rapra

EuropaBio is the European Association for Bioindustries and was created in 1996 to provide a voice for the biotech industry at the EU level. EuropaBio's mission is to promote an innovative and dynamic biotechnology-based industry in Europe.

About Smithers Rapra, is the global leader in rubber, plastics, polymer and composites testing, consulting and information products and events, with key focuses including the tire, industrial, transportation, consumer and medical industries. For more information, visit or